by admin | Jan 9, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Hayden E. Klein and Skylar Jeremias – AJMC Jana K. Dickter, MD, associate clinical professor, Division of Infectious Diseases, City of Hope, discusses a patient’s experience being the oldest person to successfully undergo a stem cell transplant while...
by admin | Jan 6, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Reference genomes used to direct the gene editor fail to account for human diversity By Jocelyn Kaiser – Science The 10-year-old gene-editing tool known as CRISPR is indispensable for engineering plants, tailoring lab animals, and probing basic biology. But...
by admin | Jan 5, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Toddler Thrives with Same Disease That Ended Siblings’ Lives By University of California San Francisco When Zahid and Sobia Bashir discovered their fetus had the same genetic disease that took the lives of two of their young children, they didn’t hesitate to sign up...
by admin | Jan 4, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Addresses major gap in effectiveness of immunotherapy Mount Sinai Press Release New York, NY – Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who...
by admin | Jan 3, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By University of California – The Guardian UC San Diego School of Medicine’s Translational Neuroscience Institute made its latest breakthrough in the treatment of spinal cord injuries after the culmination of 30 years of research. In a paper published on Aug....
by admin | Dec 31, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Joe Dangor – Mayo Clinic ROCHESTER, Minn. — Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma (PDAC). The researcher’s findings are...
